LG Chem Develops 'Smart Case' for Automated Record-Keeping of Short Stature Treatment Injections

Pediatric Growth Disorder Treatment 'Yutropinpen' Dedicated
Send Injection Records to App with a Single Button

LG Chem introduces a smart case that automatically manages growth hormone injection records by linking them with an app.

[Asia Economy Reporter Lee Gwan-ju] LG Chem is enhancing the convenience of managing growth hormone injection records for children with growth hormone deficiency and their caregivers.

On the 22nd, LG Chem announced that it will provide a smart case that automates injection record-keeping to resolve the inconvenience customers face by manually recording growth hormone injections daily.

This smart case features a digital transformation of the existing storage box provided to customers using the pediatric growth hormone treatment ‘Yutropin Pen.’ By simply pressing a button on the storage box, information such as dosage and injection site is automatically saved and recorded in the dedicated mobile app ‘EuDi.’

This helps prevent errors such as repeated injections at the same site from the previous day, and doctors can review medication adherence information through the app together with the patient to provide optimal diagnosis and prescriptions.

Starting with the supply of this smart case, LG Chem plans to further strengthen its digital-based customer experience innovation activities. To expand injection education and counseling by professional nurses, online video education has been added to the existing in-person training, and a chatbot function has been newly introduced in the app to continuously respond to customer inquiries by gathering various frequently asked questions.

Additionally, to foster a positive perception of treatment, the app has been enhanced with fun elements such as implementing various growth stage characters tailored to children’s perspectives.

An LG Chem representative said, “The Yutropin Pen smart case is an example of identifying inconveniences customers face in daily life and creating solutions. We will continue to provide differentiated customer experiences through the advancement of our digital ecosystem.”

LG Chem launched Korea’s first growth hormone ‘Yutropin’ in 1993 and has solidified its position as the market leader domestically based on abundant clinical data and a diverse product lineup.

This content was produced with the assistance of AI translation services.